Print ISSN:-2395-1354
Online ISSN:-2395-1362
CODEN : IJOSHC
Original Article
Author Details :
Volume : 10, Issue : 1, Year : 2024
Article Page : 17-22
https://doi.org/10.18231/j.ijos.2024.003
Abstract
Background: Knee osteoarthritis is prevalent globally among the aged adults with an ageing and increasingly obese population. It is also the second leading cause of disability and a heavy economic and social burden. The aim of this study is to analyse the efficacy of intra articular PRP injections in knee osteoarthritis.
Materials and Methods: This study is a prospective randomised controlled trial with duration of 6 months upon a sample size of 50 people with a diagnosis of Knee Osteoarthritis in which 2 injections of PRP were given 4 weeks apart and its result was analysed at 3 months and compared with initial pre-administration levels.
Results: In a study with 50 participants (50% males, mean age 59.02 years), intra-articular PRP injections showed significant improvement in WOMAC scores for pain (75.5% to 41.1%), stiffness (84.5% to 57.5%), and physical function (46.2% to 78.2%) at 3 months. No side effects were reported. Visual Analog scale indicated a notable decrease in pain (7.44 to 4.8).
Conclusion: In conclusion, the administration of PRP injections showed substantial decrease in pain and other associated symptoms and an increase in physical function.
Keywords: Knee osteoarthritis, Intra-articular PRP injections, Prospective randomised controlled trial, WOMAC scores, Visual analog scale, Pain management, Physical function improvement
How to cite : Suman S, Vatsa G, Anshuman K, Efficacy of intra-articular platelet -rich plasma in osteoarthritis knee. Indian J Orthop Surg 2024;10(1):17-22
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.